www.pacermonitor.com/public/case/26069026/Gordon_et_al_v_JANSSEN_RESEARCH__DEVELOPMENT_LLC_fka_JOHNSON_AND_JOHNSON_PHARMACEUTICAL_RESEARCH_AND_DEVELOPMENT_LLC_et_al

Oct 31, 2018 ... JANSSEN RESEARCH & DEVELOPMENT LLC f/k/a JOHNSON AND ... PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC et al ...

www.law360.com/cases/59dd5989ac94675a6c000001

Janssen Pharmaceutical N.V. et al, case number 2:16-cv-06997, from California ... United States of America et al v. ... Janssen Research and Development, LLC ...

law.justia.com/cases/federal/district-courts/new-york/nysdce/2017

Clark v. Cavalry Portfolio Services, LLC et al. Date: December 29, 2017. Docket Number: 1: ... Zafar Iqbal v. Teva Pharmaceuticals USA, Inc. ... A&J Construction of New York, Inc. et al ...... Janssen Pharmaceuticals, Inc. et al ..... Morales et al v.

highline.huffingtonpost.com/miracleindustry/americas-most-admired-lawbreaker/assets/documents/15/Post-Trial-Motion-Janssen.pdf

Mar 6, 2015 ... APRIL TERM 2012. NO. 1997. P.P. et al.,. Plaintiffs, v. Janssen Pharmaceuticals, Inc.; ... AND JANSSEN RESEARCH & DEVELOPMENT, LLC'S.

www.crin.org/en/library/legal-database/pp-et-al-v-janssen-pharmaceuticals-inc-and-johnson-johnson-et-al

Jul 1, 2016 ... UNITED STATES. Title: P.P. et al. v. Janssen Pharmaceuticals, Inc. and Johnson & Johnson et al. Court: Philadelphia County Court Of Common ...

www.litigationandtrial.com/files/2016/06/Invokana-Janssen-Response.pdf

Oct 12, 2016 ... ... (S.D. Ill.), Allen v. Janssen Pharmaceuticals, Inc., et al., Case No. 3:15 ... id. at * 8–*11. In Brazil v. Janssen Research & Development LLC, No.

caselaw.findlaw.com/pa-superior-court/1889831.html

JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN ... JANSSEN RESEARCH AND DEVELOPMENT, LLC NICHOLAS MURRAY, Appellant v. ... All of the cases in this mass tort action consist of male plaintiffs who allege they ...... 682, 42 U.S.C. § 201 et seq. and was approved or licensed; or is generally ...

care.diabetesjournals.org/content/diacare/38/3/403.full.pdf

HbA1c with canagliflozin 100 and 300 mg versus placebo were 20.62% (95% CI. 20.69 ... 5Janssen Research & Development, LLC, .... All potential participants completed a ..... nical editorial assistance was funded by Janssen .... et al. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4383368

Apr 1, 2015 ... Patients who switched from RLAI to PP had fewer events (26 vs. ..... This work was funded by Janssen Research & Development, LLC. ... [PubMed]; Olivares JM , Rodriguez-Morales A, Diels J, Povey M, Jacobs A, Zhao Z, et al.